Yash Optics & Lens Fund Raise of ₹49.89 Cr

Yash Optics & Lens Adverse Business Impact

Yash Optics & Lens Ltd informed the Exchange about a cyber-attack on its IT infrastructure. The company has shut down affected systems and is investigating.

Yash Optics & Lens Other Announcement

Yash Optics & Lens declared non-applicability of the Reg 27(2)(a) Corporate Governance report for Q1 FY2026-27. The SME-listed firm claims exemption under Reg 15(2) due to low capital size.

Yash Optics & Lens Annual General Meeting

Yash Optics filed 16th AGM proceedings held September 22, 2026, covering FY25-26 accounts, director re-appointment, and dividend. Voting results to be announced separately by September 24, 2026.

Yash Optics & Lens Annual Report

Yash Optics & Lens Limited issued a corrigendum to its FY 2025-26 Annual Report to incorporate previously omitted disclosures related to Annexure-B of the Statutory Auditors' Report.

Yash Optics & Lens Annual General Meeting

Yash Optics & Lens Limited has scheduled its 16th Annual General Meeting for September 22, 2026, to consider financial statements, dividend, and director appointments.

Yash Optics & Lens Other Announcement

Yash Optics & Lens Limited appointed M/s. AHJ & Associates as statutory auditors for a five-year term. This appointment follows the expiration of the previous auditors' tenure.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.